DXMII
Disease Management II
Thursday, June 2, 2022: 2:30 PM-4:30 PM
Potomac D (Gaylord National Resort & Convention Center)
2:30 PM
Characterizing Prospective Memory Errors and Their Neuropsychological Correlations in Persons with MS
Caitlyn Nguyen, HS, Trinity College;
Sarah A Raskin, PhD, Trinity College;
Aaron P Turner, Ph.D. ABPP (RP), University of Washington, VA Puget Sound Health Care System, Veterans Affairs;
Zaenab Dhari, MD, Frank H. Netter MD School of Medicine at Quinnipiac University, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England;
Lindsay O Neto, MPH, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Frank H. Netter MD School of Medicine at Quinnipiac University;
Elizabeth S Gromisch, PhD, MSCS, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, University of Connecticut School of Medicine, Frank H. Netter MD School of Medicine at Quinnipiac University
2:50 PM
Effects on Quality of Life, Disease Impact and Physical Activity of a Day Wellness Program for People Living with Multiple Sclerosis before and during the COVID-19 Pandemic.
Tiffany Malone, MSW, MSCS, Dignity Health;
John Schafer, MD, Multiple Sclerosis Achievement Center;
Lacey Sayre, CNA, Dignity Health;
Brian Hutchinson, PT, MSCS, Dignity Health
3:10 PM
COVID-19 Vaccination Intent and Uptake in People with MS: A Longitudinal Survey Study
Odelin Charron, MSc, MSE, Dell Medical School, The University of Texas at Austin;
Kenneth Onuorah, AS Candidate, Dell Medical School, The University of Texas at Austin;
Helen-Margaret O Onuorah, BA, Dell Medical School, The University of Texas at Austin;
Amanda Montague, EdM, Multiple Sclerosis Association of America;
Alexis Crispino, BA, Multiple Sclerosis Association of America;
Randa Hamden, PhD, MPH, Center for Healthcare Data, School of Public Health, The University of Texas Health Science Center at Houston;
Trudy Krause, DrPH, MS, Center for Healthcare Data, School of Public Health, The University of Texas Health Science Center at Houston;
Avery Largent, BA, Dell Medical School, The University of Texas at Austin;
Ashlea Lucas, PA-C, Dell Medical School, The University of Texas at Austin;
Ethan Meltzer, MD, Dell Medical School, The University of Texas at Austin;
Leorah Freeman, MD, PhD, Dell Medical School, The University of Texas at Austin
3:30 PM
Comparative Diagnostic and Therapeutic Strategies Among General and Multiple Sclerosis (MS) Subspecialist Neurologists – Opportunities for Education
Andrew J Solomon, MD, University of Vermont College of Medicine;
Jiwon Oh, MD PhD FRCPC, St. Michael’s Hospital, Univ of Toronto;
Robert A Bermel, MD, Mellen Center for MS, Cleveland Clinic;
Adnan Subei, DO, Memorial Healthcare System;
Chloe Gianatasio, MS, Efficient CME;
Natalie Goldberg, PhD, Efficient CME;
Wendy Cerenzia, MS, CE Outcomes, LLC;
Brian Moss, MBA, Efficient CME
3:50 PM
Predicting Satisfaction with Functioning in Psychosocial Life Areas for People with MS
Louise C Palmer, MA, Shepherd Center;
Mark Sweatman, PhD, Georgia Gwinnett College;
James Krause, Ph.D., Medical University of South Carolina;
Melinda Jarnecke, BS, Medical University of South Carolina;
Deborah Backus, PT, PhD, Shepherd Center
4:10 PM
Nabiximols Efficacy in MS Spasticity: Treatment Effects on Spasticity Numeric Rating Scale Score and Muscle Spasm Frequency in 2 Randomized Clinical Trials
Sajida Javaid, CCST, FRCP, FRCS, FCPS, Bridgend Clinic;
Fred D. Lublin, MD, Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Icahn School of Medicine at Mount Sinai;
Jacqueline A Nicholas, MD, MPH, OhioHealth Multiple Sclerosis Center;
Sylvia Klineova, MD, Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Icahn School of Medicine at Mount Sinai;
Joris Berwaerts, MD, Greenwich Biosciences, Inc.;
Robert Chinnapongse, MD, Greenwich Biosciences, Inc.;
Daniel Checketts, MSc, GW Research Ltd;
Joshua R. Steinerman, MD, Greenwich Biosciences, Inc.
